Member Info for Shakeyerbooty

Inflection Point (II)Tue 22:06Now, for those unaware, Oyster is an upstream oil and gas company with a focus on Eastern Africa. Specifically, the company holds production-sharing contracts with the governments of Djibouti and Madagascar and covers four blocks comprising of 3.5 million acres (onshore and offshore) in Djibouti and a 100% working interest in an onshore block located in northwest Madagascar and covering approximately 2.8 million acres. With a gross NCF of $22 billion and a NPV of circa $10 billion (oil price of $50), both assets have the potential to make new world-class discoveries.

Now, on May 10 2019, Oyster Oil and Gas Ltd released the following announcement:

An Annual General and Special Meeting is to be held on June 7, 2019. In line with this meeting, voting will take place to determine the following resolutions…..

• Item 5 – Settlement Transaction to approve the transfer of all of the share capital of the Company’s wholly-owned subsidiary, Oyster Oil & Gas Limited, to Northbay CapitalPartners Corp. and Gunsynd PLC, in settlement of certain indebtedness.

• Item 6 – Name Change to approve the change of the Company’s name to ZTR Acquisition Corp.

• Item 7 – To approve a consolidation of the Company’s common share capital on a basis to be determined by the Directors, and not to exceed a ratio of twenty-for-one.

Voting Instruction Forms submitted must be received by 10:00 a.m., Pacific Daylight Time, on June 5, 2019.

That's only a m/c of just under £10m.Easily achievable with the assets on offer.

A five-fold increase would only take us to 0.25p

This is now lower than before we got news of the success of NXP001.The £51m cannabinoid deal isn't even priced in fully.Another example of how bent & fraudulent the London market has become.

The £51m cannabinoid deal isn't out of thin air and Dan has told you to google out-licensing deals in the fibrosis sector..Why don't you tell us why you think this is over-valued? No phase 1,2 or 3 required here.NXP001 proven.Some pharma co's can spend billions getting a drug to market.The potential with cocrystal technology is limitless.

Obviously trying to get a cheaper entry.Markets tend to look forward.NXP001 is worth at least £100m whilst NXP002 will be worth hundreds of millions.DG has given you a clue recently.£51m cannabinoid deal already in the bag.

With the £51m cannabinoid deal,NFX001 success,fully funded with more milestone payments imminent,one-third of the world's cancer patients in China,Main Market listed,Spreadex almost out this stock is so undervalued it's unreal.Keep trying Delano.

Everyone? You really are a joker.

over 30m (enough for Spreadex to be out) and over 1000 trades.Should get a TR1 soon.The fact that NXP001 was successful should give investors greater confidence in NXP002.The CINV and Fibrosis markets are huge and the comments that DG has made today re out-licensing deals tells me where he hopes to take this co.Not forgetting the £51m cannabinoid deal of course.Still think this is undervalued for a pharma.

The point is Gizzard and what some may not realise is that there's plenty of other news due.This is just the start.

There's nothing on Twitter at all.More BS from you.

Interesting that DG mentions googling fibrosis out-licensing deals even in early stage development.Hint there?

That did surprise me.China is home to one-third of the world's cancer patients.It shows how huge the market is there for NXP001.

There is no Phase 1,2 & 3 reqd here.NSB have already commenced product registration in China and once the licensees are sorted,then this will really boom.Remember the adage 'run your winners'.Shares like this are extremely rare.

With the £51m cannabinoid deal,positive NXP001 results,more milestone payments,fully funded,Main Market,Spreadex almost out,free float getting tighter,NXP002 & 003 being developed further,broker news due & m/c getting to a level where II's will be interested,this share price has a long long way to go IMO.

is as per 15May RNS
Milestone revenues continue to validate Nuformix's business model and its commitment to reinvest early revenues back into R&D, avoiding further fund-raising at this stage whilst maximising the potential value of its cocrystal platform."

Well if you had DYOR,you'd know that there is plenty of news to come in the short term.

Yep,next the whole of the Labour Party,then Nick Clegg,Treason May & Tony Bliar.Talk about opening a can of worms.

Simongobacktobed-then wake up again and do some research.

Let's get both feet over 10p today.